Lindy has been working in the biotech, pharmaceutical and medical device industries for the past 24 years with a focus on strategic development of submission dossiers and finding novel solutions for access issues. Lindy’s background in prior pharmaceutical positions in clinical research and health economics provides a strong foundation for the strategic development of our HTA submissions work.
In addition to developing hundreds of reimbursement submission dossiers covering a wide array of therapeutic areas submitted to all payers (public, private, and hospital) across Canada, Lindy’s research has been published in peer-reviewed journals on topics related to the health and economic benefits of medications and/or drug reimbursement policy in Canada.
Agenda: Day 1 Oct 16, 2024
Agenda: Day 2 Oct 17, 2024
